Clinical trial · Interventional
5-element Music Therapy on Patients With Breast Cancer
Clinical Efficacy Study on 5-element Music Therapy on Patients With Physically and Psychologically Unbalance After Breast Cancer Surgery
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
In this study, we observed the clinical effect of using music therapy of TCM to improve the status of liver depression in patients with postoperative breast cancer patients, Second we want to explore the efficacy and advantages of traditional Chinese medicine in patients with postoperative breast cancer, and to reveal the clinical use of the efficacy and superiority.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer Female | — | UNRESOLVED | — |
| Depression, Anxiety | — | UNRESOLVED | — |
| Quality of Life | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| 5-element music therapy | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- The teatment group
- description
- 5-element misic therapy
- interventionNames
- Behavioral: 5-element music therapy
- type
- EXPERIMENTAL
- label
- The control group
- description
- health education
- interventionNames
- Behavioral: 5-element music therapy
Primary outcomes (3)
- measure
- Change From Baseline in Self-Rating Anxiety Scale (SAS) score at 3 Months
- timeFrame
- Baseline and months 3
- description
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 27 Years
- Maximum age
- 66 Years
Show eligibility criteria text
Inclusion Criteria: * the diagnosis of breast cancer in clinical stage (Ⅰ, Ⅱ, Ⅲ) and postoperative breast cancer during one month; * All participants had to have clinical depression and stagnation of liver qi; * age 27-66; * participants are conscious and willing to be followed up during the treatment. Exclusion Criteria: * Metastasis of breast cancer or serious complications; * Patients with major depressive disorder; * The past medical history of mental disorders; * The primary diseases including liver, kidney, cerebrovascular, cardiovascular and hematopoietic system diseases; * Participating in another clinical study or undergoing another intervention; * Patients with hearing loss.
References
Publications (0)
Data not yet available